{
    "Trade/Device Name(s)": [
        "UCP Compact Drug Test Cards",
        "UCP Compact Drug Test Cups",
        "UCP CompactTM Drug Test Cards",
        "UCP CompactTM Drug Test Cups"
    ],
    "Submitter Information": "UCP Biosciences, Inc.",
    "510(k) Number": "K152908",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131811",
        "K122809"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DIO",
        "DIS",
        "JXM",
        "DJC",
        "DJR",
        "DJG",
        "LCM",
        "LDJ",
        "LFG",
        "JXN"
    ],
    "Summary Letter Date": "March 21, 2016",
    "Summary Letter Received Date": "March 23, 2016",
    "Submission Date": "February 15, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Marijuana",
        "Delta-9-THC-COOH",
        "Cocaine",
        "Benzoylecgonine",
        "Amphetamine",
        "D-Amphetamine",
        "Methamphetamine",
        "D-Methamphetamine",
        "Opiates",
        "Morphine",
        "Phencyclidine",
        "Barbiturates",
        "Secobarbital",
        "Benzodiazepines",
        "Oxazepam",
        "Buprenorphine",
        "Methadone",
        "EDDP",
        "Oxycodone",
        "MDMA",
        "Propoxyphene",
        "Tricyclic Antidepressants",
        "Nortriptyline"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding lateral flow immunochromatographic assay",
        "Immunoassay"
    ],
    "Methodologies": [
        "Lateral flow",
        "Immunochromatography",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Cup",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for UCP Compact Drug Test Cards and Cups, qualitative immunochromatographic assays for rapid detection of drugs and metabolites in urine",
    "Indications for Use Summary": "OTC, qualitative, preliminary detection of drugs and metabolites in human urine as the first step in a two-step process; results to be confirmed by other methods, not for drug level monitoring",
    "fda_folder": "Toxicology"
}